The Mechanisms of Anticancer Agents by Genistein and Synthetic Derivatives of Isoflavone

  • H.-Q. Li
  • Y. Luo
  • C.-H. Qiao
N/ACitations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Genistein is the most abundant isoflavone in soybeans. It has exhibited diverse biological activities, among these, its anticancer effects is most noteworthy. Through regulating critical cell cycle genes, genistein can inhibit cancer cell growth in vivo and in vitro. It has been reported that genistein can inhibit activation of NF-κB and Akt signaling pathways to induce cell apopt1osis, both pathways are well known for their function to maintain a balance between cell survival and apoptosis. In order to find out more outstanding anticancer isoflavone agents, against cancers extended synthesis of genistein derivatives has been carried out. Some of these synthetic compounds demonstrated higher anti-cancer activity with lower doses. Based on these results, genistein and its synthetic derivatives may be an emerging new type of anticancer agents.

Cite

CITATION STYLE

APA

H.-Q. Li, Y. Luo, & C.-H. Qiao. (2012). The Mechanisms of Anticancer Agents by Genistein and Synthetic Derivatives of Isoflavone. Mini-Reviews in Medicinal Chemistry, 12(4), 350–362. https://doi.org/10.2174/138955712799829258

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free